Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2001 Apr;38(4):217–223. doi: 10.1136/jmg.38.4.217

Rett syndrome and the MECP2 gene

T Webb 1, F Latif 1
PMCID: PMC1734858  PMID: 11283201

Full Text

The Full Text of this article is available as a PDF (160.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amano K., Nomura Y., Segawa M., Yamakawa K. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome. J Hum Genet. 2000;45(4):231–236. doi: 10.1007/s100380070032. [DOI] [PubMed] [Google Scholar]
  2. Amir R. E., Van den Veyver I. B., Schultz R., Malicki D. M., Tran C. Q., Dahle E. J., Philippi A., Timar L., Percy A. K., Motil K. J. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol. 2000 May;47(5):670–679. [PubMed] [Google Scholar]
  3. Amir R. E., Van den Veyver I. B., Wan M., Tran C. Q., Francke U., Zoghbi H. Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999 Oct;23(2):185–188. doi: 10.1038/13810. [DOI] [PubMed] [Google Scholar]
  4. Ballestar E., Yusufzai T. M., Wolffe A. P. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry. 2000 Jun 20;39(24):7100–7106. doi: 10.1021/bi0001271. [DOI] [PubMed] [Google Scholar]
  5. Bienvenu T., Carrié A., de Roux N., Vinet M. C., Jonveaux P., Couvert P., Villard L., Arzimanoglou A., Beldjord C., Fontes M. MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet. 2000 May 22;9(9):1377–1384. doi: 10.1093/hmg/9.9.1377. [DOI] [PubMed] [Google Scholar]
  6. Buyse I. M., Fang P., Hoon K. T., Amir R. E., Zoghbi H. Y., Roa B. B. Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms. Am J Hum Genet. 2000 Oct 30;67(6):1428–1436. doi: 10.1086/316913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chandler S. P., Guschin D., Landsberger N., Wolffe A. P. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry. 1999 Jun 1;38(22):7008–7018. doi: 10.1021/bi990224y. [DOI] [PubMed] [Google Scholar]
  8. Cheadle J. P., Gill H., Fleming N., Maynard J., Kerr A., Leonard H., Krawczak M., Cooper D. N., Lynch S., Thomas N. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet. 2000 Apr 12;9(7):1119–1129. doi: 10.1093/hmg/9.7.1119. [DOI] [PubMed] [Google Scholar]
  9. Clarke A. Rett syndrome. J Med Genet. 1996 Aug;33(8):693–699. doi: 10.1136/jmg.33.8.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Coy J. F., Sedlacek Z., Bächner D., Delius H., Poustka A. A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3"-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum Mol Genet. 1999 Jul;8(7):1253–1262. doi: 10.1093/hmg/8.7.1253. [DOI] [PubMed] [Google Scholar]
  11. De Bona C., Zappella M., Hayek G., Meloni I., Vitelli F., Bruttini M., Cusano R., Loffredo P., Longo I., Renieri A. Preserved speech variant is allelic of classic Rett syndrome. Eur J Hum Genet. 2000 May;8(5):325–330. doi: 10.1038/sj.ejhg.5200473. [DOI] [PubMed] [Google Scholar]
  12. Dragich J., Houwink-Manville I., Schanen C. Rett syndrome: a surprising result of mutation in MECP2. Hum Mol Genet. 2000 Oct;9(16):2365–2375. doi: 10.1093/hmg/9.16.2365. [DOI] [PubMed] [Google Scholar]
  13. Engerström I. W., Forslund M. Mother and daughter with Rett syndrome. Dev Med Child Neurol. 1992 Nov;34(11):1022–1023. [PubMed] [Google Scholar]
  14. Glaze D. G., Frost J. D., Jr, Zoghbi H. Y., Percy A. K. Rett's syndrome: characterization of respiratory patterns and sleep. Ann Neurol. 1987 Apr;21(4):377–382. doi: 10.1002/ana.410210410. [DOI] [PubMed] [Google Scholar]
  15. Hagberg B. A. Rett syndrome: clinical peculiarities, diagnostic approach, and possible cause. Pediatr Neurol. 1989 Mar-Apr;5(2):75–83. doi: 10.1016/0887-8994(89)90031-3. [DOI] [PubMed] [Google Scholar]
  16. Hagberg B., Aicardi J., Dias K., Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol. 1983 Oct;14(4):471–479. doi: 10.1002/ana.410140412. [DOI] [PubMed] [Google Scholar]
  17. Hagberg B. Rett's syndrome: prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr Scand. 1985 May;74(3):405–408. doi: 10.1111/j.1651-2227.1985.tb10993.x. [DOI] [PubMed] [Google Scholar]
  18. Hampson K., Woods C. G., Latif F., Webb T. Mutations in the MECP2 gene in a cohort of girls with Rett syndrome. J Med Genet. 2000 Aug;37(8):610–612. doi: 10.1136/jmg.37.8.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Huppke P., Laccone F., Krämer N., Engel W., Hanefeld F. Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet. 2000 May 22;9(9):1369–1375. doi: 10.1093/hmg/9.9.1369. [DOI] [PubMed] [Google Scholar]
  20. Imessaoudene B., Bonnefont J. P., Royer G., Cormier-Daire V., Lyonnet S., Lyon G., Munnich A., Amiel J. MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet. 2001 Mar;38(3):171–174. doi: 10.1136/jmg.38.3.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Johnson C. A. Chromatin modification and disease. J Med Genet. 2000 Dec;37(12):905–915. doi: 10.1136/jmg.37.12.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jones P. L., Veenstra G. J., Wade P. A., Vermaak D., Kass S. U., Landsberger N., Strouboulis J., Wolffe A. P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 1998 Jun;19(2):187–191. doi: 10.1038/561. [DOI] [PubMed] [Google Scholar]
  23. Kim S. J., Cook E. H., Jr Novel de novo nonsense mutation of MECP2 in a patient with Rett syndrome. Hum Mutat. 2000 Apr;15(4):382–383. doi: 10.1002/(SICI)1098-1004(200004)15:4<382::AID-HUMU16>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  24. Kudo S. Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated. Mol Cell Biol. 1998 Sep;18(9):5492–5499. doi: 10.1128/mcb.18.9.5492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lewis J. D., Meehan R. R., Henzel W. J., Maurer-Fogy I., Jeppesen P., Klein F., Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell. 1992 Jun 12;69(6):905–914. doi: 10.1016/0092-8674(92)90610-o. [DOI] [PubMed] [Google Scholar]
  26. Meloni I., Bruttini M., Longo I., Mari F., Rizzolio F., D'Adamo P., Denvriendt K., Fryns J. P., Toniolo D., Renieri A. A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet. 2000 Sep 12;67(4):982–985. doi: 10.1086/303078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Nan X., Campoy F. J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell. 1997 Feb 21;88(4):471–481. doi: 10.1016/s0092-8674(00)81887-5. [DOI] [PubMed] [Google Scholar]
  28. Nan X., Meehan R. R., Bird A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 1993 Oct 25;21(21):4886–4892. doi: 10.1093/nar/21.21.4886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nan X., Ng H. H., Johnson C. A., Laherty C. D., Turner B. M., Eisenman R. N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998 May 28;393(6683):386–389. doi: 10.1038/30764. [DOI] [PubMed] [Google Scholar]
  30. Nan X., Tate P., Li E., Bird A. DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol. 1996 Jan;16(1):414–421. doi: 10.1128/mcb.16.1.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Orrico A., Lam C., Galli L., Dotti M. T., Hayek G., Tong S. F., Poon P. M., Zappella M., Federico A., Sorrentino V. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett. 2000 Sep 22;481(3):285–288. doi: 10.1016/s0014-5793(00)01994-3. [DOI] [PubMed] [Google Scholar]
  32. Sassone-Corsi P., Mizzen C. A., Cheung P., Crosio C., Monaco L., Jacquot S., Hanauer A., Allis C. D. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science. 1999 Aug 6;285(5429):886–891. doi: 10.1126/science.285.5429.886. [DOI] [PubMed] [Google Scholar]
  33. Sirianni N., Naidu S., Pereira J., Pillotto R. F., Hoffman E. P. Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet. 1998 Nov;63(5):1552–1558. doi: 10.1086/302105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tate P., Skarnes W., Bird A. The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat Genet. 1996 Feb;12(2):205–208. doi: 10.1038/ng0296-205. [DOI] [PubMed] [Google Scholar]
  35. Thomas G. H. High male:female ratio of germ-line mutations: an alternative explanation for postulated gestational lethality in males in X-linked dominant disorders. Am J Hum Genet. 1996 Jun;58(6):1364–1368. [PMC free article] [PubMed] [Google Scholar]
  36. Van den Veyver I. B., Zoghbi H. Y. Methyl-CpG-binding protein 2 mutations in Rett syndrome. Curr Opin Genet Dev. 2000 Jun;10(3):275–279. doi: 10.1016/s0959-437x(00)00083-6. [DOI] [PubMed] [Google Scholar]
  37. Villard L., Kpebe A., Cardoso C., Chelly P. J., Tardieu P. M., Fontes M. Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology. 2000 Oct 24;55(8):1188–1193. doi: 10.1212/wnl.55.8.1188. [DOI] [PubMed] [Google Scholar]
  38. Wan M., Lee S. S., Zhang X., Houwink-Manville I., Song H. R., Amir R. E., Budden S., Naidu S., Pereira J. L., Lo I. F. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet. 1999 Dec;65(6):1520–1529. doi: 10.1086/302690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Watson P., Black G., Ramsden S., Barrow M., Super M., Kerr B., Clayton-Smith J. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet. 2001 Apr;38(4):224–228. doi: 10.1136/jmg.38.4.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Webb T., Clarke A., Hanefeld F., Pereira J. L., Rosenbloom L., Woods C. G. Linkage analysis in Rett syndrome families suggests that there may be a critical region at Xq28. J Med Genet. 1998 Dec;35(12):997–1003. doi: 10.1136/jmg.35.12.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Webb T., Watkiss E. A comparative study of X-inactivation in Rett syndrome probands and control subjects. Clin Genet. 1996 Apr;49(4):189–195. doi: 10.1111/j.1399-0004.1996.tb03285.x. [DOI] [PubMed] [Google Scholar]
  42. Xiang F., Buervenich S., Nicolao P., Bailey M. E., Zhang Z., Anvret M. Mutation screening in Rett syndrome patients. J Med Genet. 2000 Apr;37(4):250–255. doi: 10.1136/jmg.37.4.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Xiang F., Zhang Z., Clarke A., Joseluiz P., Sakkubai N., Sarojini B., Delozier-Blanchet C. D., Hansmann I., Edström L., Anvret M. Chromosome mapping of Rett syndrome: a likely candidate region on the telomere of Xq. J Med Genet. 1998 Apr;35(4):297–300. doi: 10.1136/jmg.35.4.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yusufzai T. M., Wolffe A. P. Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res. 2000 Nov 1;28(21):4172–4179. doi: 10.1093/nar/28.21.4172. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES